Search research articles
Contact Us
Filters
Showing results (971-980 of 1,105) with videos related to
Page
of 111
Sort By:
Veterinary Parasitology
|
February 12, 2013
Isolation and genetic characterization of Toxoplasma gondii from mute swan (Cygnus olor) from the USA
J P Dubey, S Choudhary, O C H Kwok, et al.
Nature Genetics
|
May 22, 2002
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
Jing Li, Ying Yang, Yue Peng, et al.
FEMS Microbiology Ecology
|
December 8, 2011
Field and laboratory studies on the bioconversion of coal to methane in the San Juan Basin
Boris Wawrik, Margarita Mendivelso, Victoria A Parisi, et al.
Cancer Letters
|
May 28, 2018
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis
Jie Wu, Zerun Jiang, Chen Chen, et al.
NPJ Breast Cancer
|
March 2, 2021
Unmasking the immune microecology of ductal carcinoma in situ with deep learning
Priya Lakshmi Narayanan, Shan E Ahmed Raza, Allison H Hall, et al.
Stem Cell Reports
|
August 5, 2022
Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential
Marissa J Stutzman, C S John Kim, David J Tester, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Prognostic Implications of Codon-Specific <i>KRAS</i> Mutations in Localized and Advanced Stages of Pancreatic Cancer
Sara Raji, Hamed Zaribafzadeh, Tyler Jones, et al.
Circulation. Arrhythmia and Electrophysiology
|
August 28, 2025
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data
Alexander Chang, Halil Beqaj, Leah Sittenfeld, et al.
International Journal of Cancer
|
July 24, 2009
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas
Cathrine Hoyo, Joellen M Schildkraut, Susan K Murphy, et al.
Oncotarget
|
January 1, 2017
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
Laura E Wright, Ahmed A Harhash, Wende M Kozlow, et al.
Page
of 111
Search research articles
Search
Showing results (971-980 of 1,105) with videos related to
Sort By:
Page
of 111
Veterinary Parasitology
|
February 12, 2013
Isolation and genetic characterization of Toxoplasma gondii from mute swan (Cygnus olor) from the USA
J P Dubey, S Choudhary, O C H Kwok, et al.
Nature Genetics
|
May 22, 2002
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
Jing Li, Ying Yang, Yue Peng, et al.
FEMS Microbiology Ecology
|
December 8, 2011
Field and laboratory studies on the bioconversion of coal to methane in the San Juan Basin
Boris Wawrik, Margarita Mendivelso, Victoria A Parisi, et al.
Cancer Letters
|
May 28, 2018
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis
Jie Wu, Zerun Jiang, Chen Chen, et al.
NPJ Breast Cancer
|
March 2, 2021
Unmasking the immune microecology of ductal carcinoma in situ with deep learning
Priya Lakshmi Narayanan, Shan E Ahmed Raza, Allison H Hall, et al.
Stem Cell Reports
|
August 5, 2022
Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential
Marissa J Stutzman, C S John Kim, David J Tester, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Prognostic Implications of Codon-Specific <i>KRAS</i> Mutations in Localized and Advanced Stages of Pancreatic Cancer
Sara Raji, Hamed Zaribafzadeh, Tyler Jones, et al.
Circulation. Arrhythmia and Electrophysiology
|
August 28, 2025
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data
Alexander Chang, Halil Beqaj, Leah Sittenfeld, et al.
International Journal of Cancer
|
July 24, 2009
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas
Cathrine Hoyo, Joellen M Schildkraut, Susan K Murphy, et al.
Oncotarget
|
January 1, 2017
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
Laura E Wright, Ahmed A Harhash, Wende M Kozlow, et al.
Page
of 111